Skip to Main Content

++

INTRODUCTION

++

Epidemiology

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
Epidemiology
Incidence: 52,630 (Estimated new cases for 2014 in the United States) Stage at Presentation
Localized: 72% Stage I: 79%
24.3 per 100,000 women per year. Regional: 16% Stage II: 12.5%
Deaths: Estimated 8,590 in 2014  Distant:  8% Stage III: 13.3%
Median age at diagnosis: 62 years Unstaged:  4% Stage IV:  4%

Modified from Creasman WT et al. J Epidemiol Biostat 2001;6:47–86

Siegel R et al. CA Cancer J Clin 2014;64:9–29

Surveillance, Epidemiology and End Results (SEER) Program, available from http://seer.cancer.gov (accessed in 2013)

++

Pathology

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
Pathology

Endometrioid

  • Ciliated adenocarcinoma

  • Secretory adenocarcinoma

  • Adenocarcinoma with squamous differentiation–Adenosquamous

75–80%
Serous <10%
Clear cell 4%
Mucinous 1%
Squamous <1%
Mixed 10%
Undifferentiated  

Kurman RJ, Ellenson LH, Ronnett BM editors. Blaustein's Pathology of the Female Genital Tract. 6th ed: Springer; 2011

++

Work-up

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
Work-up
Stage I

H&P

CBC with platelet count

Chest x-ray

Cervical cytology

Stage II Consider endocervical curettage or cervical biopsy
Stages III/IV CA-125 MRI/CT as clinically indicated

++

Staging

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
Staging
TNM Category FIGO Stage Primary Tumor (T)
TX   Primary tumor cannot be assessed
T0   No evidence of primary tumor
Tis   Carcinoma in situ (preinvasive carcinoma)
T1 I Tumor confined to corpus uteri
T1a IA Tumor limited to endometrium or invades less than one-half of the myometrium
T1b IB Tumor invades one-half or more of the myometrium
T2 II Tumor invades stromal connective tissue of the cervix but does not extend beyond uterus
T3a IIIA Tumor involves serosa and/or adnexa (direct extension or metastasis)
T3b IIIB Vaginal involvement (direct extension or metastasis) or parametrial involvement
T4 IVA Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4)

FIGO staging no longer includes stage 0 (Tis)

Endocervical glandular involvement only should be considered as stage I and not stage II

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
Staging
TNM Category FIGO Stage Regional Lymph Nodes (N)
NX   Regional lymph nodes cannot be assessed
N0   No regional lymph node metastasis
N1 IIIC1 Regional lymph node metastasis to pelvic lymph nodes
N2 IIIC2 Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes
Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
Staging
TNM Category FIGO Stage Distant Metastasis (M)
M0   No distant metastasis (no pathologic M0; use clinical M to complete stage group)
MI IVB Distant metastasis (includes metastasis to inguinal lymph nodes intraperitoneal disease, or lung, liver, or bone. It excludes metastasis to paraaortic lymph nodes, vagina, pelvic serosa, or adnexa)

 

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.